肺癌筛查转诊的医疗资源不足患者戒烟:随机临床试验
本研究比较四种戒烟策略在医疗资源不足的肺癌筛查转诊吸烟者中的效果。随机分配3259例,3220例纳入分析。结果显示,在常规建议转诊基础上增加经济激励可提高6个月持续戒烟率(8.8% vs 4.3%),而免费药物无额外获益。
要点
- 经济激励使6个月持续戒烟率提高4.6个百分点(95%CI 2.1%-7.0%)。
- 经济激励优于免费药物(差异4.1%,95%CI 1.7%-6.4%)。
核心结论
- 在医疗资源不足的肺癌筛查转诊吸烟者中,常规建议转诊加经济激励可提高6个月持续戒烟率。
- 常规建议转诊加免费药物未显著优于常规建议转诊。
研究设计与样本
- 随机临床试验纳入美国4个卫生系统(5个中心)的当前吸烟且转诊肺癌筛查者,自我认同为黑人、西班牙裔、农村居民或低社会经济地位。
- 共筛查9963例,随机3259例,3220例纳入主要分析。
- 干预分为四组:常规建议转诊;常规加免费药物;常规加免费药物加经济激励(最高600美元);常规加免费药物加经济激励加移动健康工具。
- 主要终点为生化确认的6个月持续烟草戒断(可替宁、新烟碱或碳氧血红蛋白检测)。
主要发现
- 6个月持续烟草戒断率:常规建议转诊4.3%,加免费药物5.1%,加经济激励8.8%,加移动健康工具7.2%。
临床怎么用
- 对医疗资源不足的肺癌筛查转诊吸烟者,可考虑在常规建议转诊基础上增加经济激励以提高戒烟率。
- 常规建议转诊加免费药物方案未显示额外获益,需结合其他措施。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The Centers for Medicare & Medicaid Services requires that health systems offer smoking cessation services to patients undergoing lung cancer screening. However, the most effective methods to achieve smoking cessation among medically underserved patients undergoing lung cancer screening are unknown. OBJECTIVE: To compare the effectiveness of 4 strategies for promoting smoking cessation among medically underserved persons referred for lung cancer screening. DESIGN, SETTING, AND PARTICIPANTS: This randomized clinical trial included currently smoking individuals referred for lung cancer screening at 4 US health systems (5 centers) who identified as Black, Hispanic, living in a rural area, or being of low socioeconomic status. The first participant was enrolled on May 17, 2021, and the date of last follow-up was April 29, 2025. INTERVENTION: Patients were randomized to 1 of 4 groups. Participants received either an ask-advise-refer strategy to smoking cessation services (usual care); usual care plus free pharmacotherapy (ie, nicotine replacement and reimbursement for varenicline or bupropion); usual care, free pharmacotherapy, and financial incentives up to $600 contingent on biochemically confirmed smoking cessation; or usual care, free pharmacotherapy, and financial incentives plus a mobile health tool motivating patients to think about their future health. MAIN OUTCOMES AND MEASURES: The primary end point was biochemically confirmed, sustained tobacco abstinence through 6 months, measured with cotinine, anabasine, or carboxyhemoglobin. RESULTS: Of the 9963 patients assessed for eligibility, 3259 patients were randomized and 3220 were included in the primary analysis. The median (IQR) age was 61.1 (56.6-66.0) years, 1948 (60.3%) were female, 823 (25.5%) were Black, 287 (8.9%) were Hispanic, 1251 (38.8%) lived in rural areas, 1519 (74.9%) had low socioeconomic status, and 1792 (55.5%) reported smoking more than 10 cigarettes per day at enrollment. Sustained tobacco abstinence rates through 6 months were 4.3% with usual care, 5.1% with the addition of pharmacotherapy, 8.8% with the addition of financial incentives, and 7.2% with the addition of mobile health tool. Adding financial incentives increased the adjusted rate of sustained tobacco abstinence compared with usual care (difference, 4.6% [95% CI, 2.1%-7.0%]; P < .001) and usual care plus free pharmacotherapy (difference, 4.1% [95% CI, 1.7%-6.4%]; P < .001). Adding free pharmacotherapy to ask-advise-refer was not superior to ask-advise-refer alone (difference, 0.5% [95% CI, -1.7% to 2.6%]; P = .66). CONCLUSIONS AND RELEVANCE: Among medically underserved adults who currently smoked cigarettes and were referred for lung cancer screening, rates of sustained tobacco abstinence were higher through 6 months with addition of financial incentives compared with ask-advise-refer alone or with addition of free pharmacotherapy. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04798664.
引用
- Hart JL, Vachani A, Neslund-Dudas CM, et al. Smoking Cessation Among Underserved Patients Referred for Lung Cancer Screening: A Randomized Clinical Trial. JAMA. 2026. PMID: 42832220. doi:10.1001/jama.2026.17192
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。